Cencora | COR - Cash And Equivalent


Cencora reported $2.82B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Ambu A/S DKK 536M 169M Sep/2026
Amplifon EUR 711.99M 402.44M Jun/2026
Apollo Hospitals Enterprise Ltd INR 8.11B 5.49B Mar/2026
Brookdale Senior Living USD 323.37M 47.01M Sep/2026
Cencora USD 2.82B 638.79M Jun/2026
Coloplast 911M 497M Sep/2023
Convatec Group USD 64.7M 32.2M Dec/2024
Diasorin EUR 120.8M 52.28M Jun/2026
Encompass Health USD 76.2M 31.5M Sep/2026
Enovis USD 13.04M 475K Sep/2026
GE HealthCare Technologies USD 2.83B 747M Sep/2026
Gulf Medical Proj AED 74.52M 101.52M Mar/2025
Hoya 555.49B 18.6B Jun/2026
Max Healthcare Institute Limited 14.68B 6.31B Mar/2023
Med Life RON 168.41M 16.94M Mar/2026
Oriola-kd EUR 107.6M 13.9M Sep/2025
Pediatrix Medical Group USD 311.92M 23.04M Sep/2026
Rede D'or Sao Luiz BRL 5.41B 1.7B Mar/2026
Siemens Healthineers EUR 2.54B 182M Sep/2026
Solventum Corp USD 451M 48M Sep/2026
Sonova Holding CHF 413.9M 134.3M Jun/2023
Supermax Corporation Bhd MYR 612.31M 25.28M Jun/2026
Veradigm USD 492.6M 7.57M Sep/2022
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026